Once president of group research at Roche Holdings, Knowles now joins the board at Adaptimmune as a non-executive director.
He joins the firm's current chief operating officer Helen Tayton-Martin, who will become executive director.
in-Pharmatechnologist.com takes a look at the People on the Move this week.
The WHO Executive Board prepares for a special Ebola meeting, CEO leaves troubled biotech, and senior staff...
Novartis's CEO becomes President of EFPIA, a new head of R&D for Genentech, and more People on...